Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study
- 1 May 2017
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 54, 419-428
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Bisphosphonates: The first 40yearsBone, 2011
- Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthaseBone, 2011
- Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopyBone, 2009
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacyOsteoporosis International, 2008
- Bisphosphonates in cancer therapyCancer Letters, 2007
- Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer PatientsClinical Cancer Research, 2007
- Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cellsBiochemical and Biophysical Research Communications, 2007
- Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation‐dependent signaling pathwaysJournal of Thrombosis and Haemostasis, 2006
- BisphosphonatesArchives of Endocrinology and Metabolism, 2006
- Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell DeathJournal of Biological Chemistry, 2003